Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.

Jason K Russell, Alexander C Conley, Jo Ellen Wilson, Paul A Newhouse
{"title":"Cholinergic System Structure and Function Changes in Individuals with Down Syndrome During the Development of Alzheimer's Disease.","authors":"Jason K Russell, Alexander C Conley, Jo Ellen Wilson, Paul A Newhouse","doi":"10.1007/7854_2024_523","DOIUrl":null,"url":null,"abstract":"<p><p>Adults with Down syndrome represent the population with the highest risk of developing Alzheimer's disease worldwide. The cholinergic system is known to decline in Alzheimer's disease, with this decline responsible for many of the cognitive deficits that develop. The integrity of the cholinergic system across the lifespan in individuals with Down syndrome is not well characterized. Small fetal and infant post-mortem studies suggest an intact cholinergic projection system with a potential reduction in cholinergic receptors, while post-mortem studies in adults with Down syndrome reveal an age-related decrease in cholinergic integrity. Advances in magnetic resonance imaging (MRI) and positron emission tomography (PET) over the last 20 years have allowed for studies investigating the changes in cholinergic integrity across aging and during the development of Alzheimer's disease. One large cross-sectional study demonstrated reduced cholinergic basal forebrain volume measured by MRI associated with increasing Alzheimer's disease pathology. In a small cohort of adults with Down syndrome, we have recently reported that PET measures of cholinergic integrity negatively correlated with amyloid accumulation. New disease-modifying treatments for Alzheimer's disease and treatments under development for Alzheimer's disease in Down syndrome have the potential to preserve the cholinergic system, while treatments targeting the cholinergic system directly may be used in conjunction with disease-modifying therapies to improve cognitive function further. A greater understanding of cholinergic neuronal and receptor integrity across the lifespan in individuals with Down syndrome will provide insights as to when targeting the cholinergic system is an appropriate therapeutic option and, in the future, maybe a valuable screening tool to identify individuals that would most benefit from cholinergic interventions.</p>","PeriodicalId":11257,"journal":{"name":"Current topics in behavioral neurosciences","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-11-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current topics in behavioral neurosciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/7854_2024_523","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Neuroscience","Score":null,"Total":0}
引用次数: 0

Abstract

Adults with Down syndrome represent the population with the highest risk of developing Alzheimer's disease worldwide. The cholinergic system is known to decline in Alzheimer's disease, with this decline responsible for many of the cognitive deficits that develop. The integrity of the cholinergic system across the lifespan in individuals with Down syndrome is not well characterized. Small fetal and infant post-mortem studies suggest an intact cholinergic projection system with a potential reduction in cholinergic receptors, while post-mortem studies in adults with Down syndrome reveal an age-related decrease in cholinergic integrity. Advances in magnetic resonance imaging (MRI) and positron emission tomography (PET) over the last 20 years have allowed for studies investigating the changes in cholinergic integrity across aging and during the development of Alzheimer's disease. One large cross-sectional study demonstrated reduced cholinergic basal forebrain volume measured by MRI associated with increasing Alzheimer's disease pathology. In a small cohort of adults with Down syndrome, we have recently reported that PET measures of cholinergic integrity negatively correlated with amyloid accumulation. New disease-modifying treatments for Alzheimer's disease and treatments under development for Alzheimer's disease in Down syndrome have the potential to preserve the cholinergic system, while treatments targeting the cholinergic system directly may be used in conjunction with disease-modifying therapies to improve cognitive function further. A greater understanding of cholinergic neuronal and receptor integrity across the lifespan in individuals with Down syndrome will provide insights as to when targeting the cholinergic system is an appropriate therapeutic option and, in the future, maybe a valuable screening tool to identify individuals that would most benefit from cholinergic interventions.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
唐氏综合征患者胆碱能系统结构和功能在阿尔茨海默病发展过程中的变化。
患有唐氏综合症的成年人是全世界罹患阿尔茨海默病风险最高的人群。众所周知,胆碱能系统会在阿尔茨海默病中衰退,而这种衰退是许多认知障碍发生的原因。唐氏综合症患者在整个生命周期中胆碱能系统的完整性还没有得到很好的描述。小规模的胎儿和婴儿死后研究表明,胆碱能投射系统完好,但胆碱能受体可能减少,而对成年唐氏综合症患者的死后研究则显示,胆碱能完整性的下降与年龄有关。过去 20 年来,磁共振成像(MRI)和正电子发射断层扫描(PET)技术的进步使人们能够研究胆碱能完整性在衰老和阿尔茨海默病发展过程中的变化。一项大型横断面研究表明,通过核磁共振成像测量的胆碱能基底前脑体积的减少与阿尔茨海默病病理变化的增加有关。最近,我们在一个小型唐氏综合征成人队列中发现,PET测定的胆碱能完整性与淀粉样蛋白累积呈负相关。针对阿尔茨海默病的新型疾病调节疗法和正在开发的针对唐氏综合征阿尔茨海默病的疗法有可能保护胆碱能系统,而直接针对胆碱能系统的疗法可与疾病调节疗法结合使用,以进一步改善认知功能。进一步了解唐氏综合症患者在整个生命周期中胆碱能神经元和受体的完整性,将有助于深入了解何时以胆碱能系统为靶点是一种合适的治疗选择,而且在未来,这也许是一种有价值的筛查工具,可用于确定哪些患者最能从胆碱能干预措施中获益。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Current topics in behavioral neurosciences
Current topics in behavioral neurosciences Neuroscience-Behavioral Neuroscience
CiteScore
4.80
自引率
0.00%
发文量
103
期刊最新文献
Computational Mechanisms of Information-Seeking in Anxiety. Fear and Anxiety in Schizophrenia: A Focus on Development, Assessment, and Mechanisms. Genetic Tools in Rodents to Study Cannabinoid Functions. Fears Worth Testing Out: A Systematic Review of the Neural Mechanisms of Treatment Outcome for Anxiety-Related Disorders. Sensory Processing and Anxiety: Within and Beyond the Autism Spectrum.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1